Latest News PHAC Osteoporosis Key Findings August 18, 2021 Osteoporosis Canada has been working closely with the Public Health Agency of Canada (PHAC) over the past few years assisting in […]
We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]
We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]
Media Release Osteoporosis Canada and the International Osteoporosis Foundation underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis. […]
This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older. It reports on administrative data from the Canadian […]
2023 Clinical Practice Guideline Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. This guideline is an update of the 2010 Osteoporosis Canada clinical practice […]
Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]
The Osteoporosis Exemplary Care Program (OECP) at St. Michael’s Hospital in Toronto, Ontario has been a leader in the FLS movement in Canada and worldwide. OECP was founded in 2002 […]
